A Phase 2a, Randomised, Double Blind, Placebo-Controlled Study of IMR-687 in Adult Patients with Sickle Cell Anaemia (Homozygous HbSS or Sickle-B thalassemia.

Administered By

Medicine, Hematology

Awarded By

Imara, Inc.

Contributors

Shah, Nirmish Ramesh Principal Investigator

Start/End

November 12, 2019 - September 14, 2021